Astellas
Astellas Pharma US, Inc. is committed to providing patients, customers, community and employees with a bright future by changing tomorrow. Our commitment is made possible because we are a different kind of pharmaceutical company. This is apparent not only in what we do, but how we do it.
RELATED ARTICLES
Fighting Cancer at the Personal Level
Cancer takes 600,000 lives annually in the U.S., but advanced immuno-oncology treatments are making huge differences.
Improving Health Care Quality While Reducing Costs
The latest immunosuppressant therapies are transforming the lives of patients in ways beyond physical success. Innovations in treatment not only help extend life, they can also reduce health care costs to give back confidence and hope to patients for the future.
At the Heart of Transplantation
Transplant researchers aren't missing a beat when it comes to pioneering treatments to prevent transplant rejection and the recurrence of the original disease. Their latest findings are helping patients get a second chance at life.
Researcher Profile: Salim Mujais
Salim and his team at Astellas serve as the bridge between drug discovery and drug delivery.
How the War on Cancer is Evolving
The progress we have made may only foreshadow a much more intensive fight against cancer that is likely to be characterized by small steps towards a cure and efforts to improve quality of life rather than focus on big breakthroughs alone.
Biopharmaceutical Researchers Are Unlocking the Promise of Personalized Medicine
In some cases, a medicine can work well for one patient, but not another with the same disease. With personalized medicine, biopharmaceutical industry researchers like Dr. Bernie Zeiher are unlocking the reasons why.
POPULAR ARTICLES
HIV/AIDS: From An Acute Fatal Disease to A Chronic, Manageable Condition
<p>The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.</p>
READ MORE
Combatting Sickle Cell Disease with Cell & Gene Therapy
<p><span><span><span><a><span lang="EN"><span>America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.</span></span></a></span></span></span></p>
READ MORE
Why Has Research into Alzheimer's Disease Been So Hard?
<p>Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?</p>
READ MORE
5 Recent Developments Advancing Vaccines
As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.
READ MORE
The Innovation Ecosystem Fuels Breakthroughs
Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.
READ MORE
Understanding mRNA Vaccines
Scientists are breaking barriers with mRNA technology, one of the approaches used to develop COVID-19 vaccines.
READ MORE
Protecting Alzheimer's Research
15 million people will live with Alzheimer's by 2060. We're working to change that.
READ MORE